Resumen de acción 867
China Medical System Holdings Limited, sociedad de cartera de inversiones, fabrica, vende, comercializa y promociona productos farmacéuticos en la República Popular China.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 6/6 |
| Crecimiento futuro | 2/6 |
| Resultados anteriores | 2/6 |
| Salud financiera | 6/6 |
| Dividendos | 4/6 |
Recompensas
Análisis de riesgos
Competidores de China Medical System Holdings Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | HK$6.41 |
| Máximo en 52 semanas | HK$15.86 |
| Mínimo de 52 semanas | HK$6.23 |
| Beta | 0.83 |
| 11 mes Cambio | -2.44% |
| Variación en 3 meses | -10.97% |
| Cambio de 1 año | -50.00% |
| 3Variación en 3 años | -59.33% |
| Variación en 5 años | -10.97% |
| Variación desde la OPV | 113.10% |
Noticias y actualizaciones recientes
Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings
Jul 15
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22Recent updates
Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings
Jul 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
May 03We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package
May 02China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 19China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
Mar 29Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%
Mar 28China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up
Dec 21Is China Medical System Holdings (HKG:867) A Risky Investment?
Dec 04If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Nov 15China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342
Aug 31China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Aug 30Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today
Aug 07We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease
May 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 26An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued
Feb 05China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly
Dec 26If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Dec 08Is China Medical System Holdings (HKG:867) Using Too Much Debt?
Sep 14China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year
Aug 25Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?
Aug 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued
Jul 08Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
May 16Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Apr 10China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28
Mar 22If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late
Feb 09Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Dec 25Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
Nov 10China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Sep 25China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32
Aug 26Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching
Jul 30An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued
Jun 27China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Jun 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 20Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?
Mar 25Shareholders Are Loving China Medical System Holdings Limited's (HKG:867) 3.0% Yield
Mar 08Rentabilidad de los accionistas
| 867 | HK Pharmaceuticals | Mercado HK | |
|---|---|---|---|
| 7D | -2.0% | -1.9% | -1.9% |
| 1Y | -50.0% | -10.0% | -6.7% |
Rentabilidad vs. Industria: 867 obtuvo unos resultados inferiores a los del sector Hong Kong Pharmaceuticals , que el año pasado arrojó un rendimiento del -15.9%.
Rentabilidad vs. Mercado: 867 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -10.1% el año pasado.
Volatilidad de los precios
| 867 volatility | |
|---|---|
| 867 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.1% |
| 10% least volatile stocks in HK Market | 3.6% |
Precio estable de las acciones: 867 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 867 (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1995 | 5,701 | Kong Lam | web.cms.net.cn/zh/home/ |
China Medical System Holdings Limited, sociedad de cartera de inversiones, fabrica, vende, comercializa y promociona productos farmacéuticos en la República Popular China. Entre sus productos figuran VALTOCO, un aerosol nasal de diazepam para tratar las crisis convulsivas; Plendil para el tratamiento de la hipertensión y la angina de pecho estable; XinHuoSu para tratar la insuficiencia cardiaca aguda; Deanxit para la depresión leve a moderada, la ansiedad y las afecciones psicosomáticas; METOJECT, una inyección de metotrexato para la psoriasis invalidante recalcitrante; y Ursofalk para el tratamiento de los cálculos de colesterol en la vesícula biliar, la enfermedad hepática colestásica y la gastritis por reflujo biliar. La empresa también ofrece Salofalk para el tratamiento de la colitis ulcerosa y la enfermedad de Crohn; Bioflor para el tratamiento de la diarrea; Combizym para la dispepsia; ILUMETRI, una inyección de tildrakizumab para tratar la psoriasis en placas de moderada a grave; Augentropfen Stulln Mono colirio para tratar la degeneración senil de la mácula y la astenopía; e Hirudoid para los traumatismos contusos con o sin hematomas y la flebitis superficial insoportable.
Resumen de fundamentos de China Medical System Holdings Limited
| Estadísticas fundamentales de 867 | |
|---|---|
| Capitalización bursátil | HK$15.64b |
| Beneficios(TTM) | HK$2.59b |
| Ingresos (TTM) | HK$8.63b |
6.0x
Ratio precio-beneficio (PE)1.8x
Ratio precio-ventas (PS)¿Está 867 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 867 | |
|---|---|
| Ingresos | CN¥8.01b |
| Coste de los ingresos | CN¥1.94b |
| Beneficio bruto | CN¥6.08b |
| Otros gastos | CN¥3.68b |
| Beneficios | CN¥2.40b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.98 |
| Margen bruto | 75.82% |
| Margen de beneficio neto | 29.96% |
| Ratio deuda/patrimonio | 8.3% |
¿Cómo se ha desempeñado 867 a largo plazo?
Ver rendimiento histórico y comparativa